Georgia Li

Identification of the platelet ADP receptor targeted by antithrombotic drugs

Gunther Hollopeter, Hans‐Michael Jantzen, D Vincent et al. · Nature · 2001 · 1.4K citations

Medicine, Hematology, Pharmacology +14

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials

Quentin M. Anstee, Eric Lawitz, Naim Alkhouri et al. · Hepatology · 2019 · 266 citations

Medicine, Internal Medicine, Pathology +17

The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis

Michael Trauner, Aliya Gulamhusein, Bilal Hameed et al. · Hepatology · 2019 · 259 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Inhibition of Transforming Growth Factor β Signaling Reduces Pancreatic Adenocarcinoma Growth and Invasiveness

N. J. Gaspar, Lingyun Li, Ann M. Kapoun et al. · Molecular Pharmacology · 2007 · 118 citations

Medicine, Oncology, Pharmacology +17